Table 5

Predictors of No Health Benefit Following TAVR at 1 Year in Patients With Moderate or Severe Chronic Lung Disease

UnivariableMultivariable
Odds Ratio (95% CI)p ValueOdds Ratio (95% CI)p Value
Unplanned weight loss2.63 (1.09–6.34)0.0326.13 (1.57–24.0)0.009
≥2 ADL deficits2.28 (1.23–4.22)0.009
Wheelchair bound2.15 (1.08–4.27)0.029
STS PROM >7%2.13 (1.24–3.64)0.0062.52 (0.24–5.14)0.011
Assisted living2.12 (1.18–3.80)0.012
Falls in past 6 months2.07 (1.04–4.12)0.0392.43 (0.91–6.51)0.077
Peripheral vascular disease2.01 (1.23–3.29)0.005
Home oxygen1.88 (1.17–3.01)0.009
Baseline AV gradient, per 10 mm Hg0.82 (0.70–0.95)0.0090.76 (0.62–0.92)0.006
Percent predicted DLCO, per 10%0.81 (0.70–0.94)0.0060.79 (0.67–0.94)0.007

AV = aortic valve; TAVR = transcatheter aortic valve replacement; other abbreviations as in Tables 1, 2, and 4.

  • Univariable predictors with a p ≤0.05 were included in the multivariable analysis. Stepwise method with thresholds for entry and exit = 0.10.

  • From the logistic model.